Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06843538
PHASE3

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Sponsor: TriHealth Inc.

View on ClinicalTrials.gov

Summary

The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).

Official title: Peri-operative Tamsulosin and Impact on Voiding Trial Following Outpatient Urogynecology Surgery: a Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

166

Start Date

2025-02-03

Completion Date

2026-06-01

Last Updated

2025-02-25

Healthy Volunteers

No

Interventions

DRUG

Tamsulosin

This intervention will investigate if tamsulosin will decrease postoperative urinary retention. Subjects will be directed to start taking the medication 5-7 days prior to their procedure; as previous studies have shown, this is when tamsulosin reaches its steady state. Patients will continue to take their assigned pills for 7 days postoperatively.

DRUG

Placebo

This intervention will ensure blinding and an accurate measure of the real effect of tamsulosin.

Locations (1)

TriHealth

Cincinnati, Ohio, United States